Condrosulf Orogel 800 gel-orale in bustine
Country: Switzerland
Language: German
Source: Swissmedic (Swiss Agency for Therapeutic Products)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
chondroitini sulfas natricus
Available from:
IBSA Institut Biochimique SA
ATC code:
M01AX25
INN (International Name):
chondroitini sulfas natricus
Pharmaceutical form:
gel-orale in bustine
Composition:
chondroitini sulfas natricus 800 mg, xylitolum, cellulosum microcristallinum, aqua, aromatica (vaniglia), aromatica (caramello), E 202, E 211 6 mg, ad gelatum, pro charta corresp. natrium 74 mg.
Class:
B
Therapeutic group:
Biotechnologika
Therapeutic area:
Antiartrosico
Authorization date:
1996-02-05
